SyntekaBio, Inc. (KOSDAQ:226330)

SyntekaBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13,397	16,346	12,066	19,668	35,342	13,709
Short-Term Investments	-	-	-	-	-	39,000
Cash & Short-Term Investments	13,397	16,346	12,066	19,668	35,342	52,709
Cash Growth	15.78%	35.47%	-38.65%	-44.35%	-32.95%	28.27%
Accounts Receivable	802.83	846.46	0.19	0.24	1.07	55.04
Other Receivables	138.52	38.22	-	40.67	132.56	113.44
Receivables	941.35	884.69	0.19	40.91	133.63	168.48
Prepaid Expenses	206.55	65.15	136.53	374.72	351.44	185.38
Other Current Assets	342.97	134.93	362.17	1,896	1,670	5,131
Total Current Assets	14,888	17,430	12,565	21,980	37,497	58,193
Property, Plant & Equipment	28,453	28,738	30,672	30,461	17,475	9,054
Other Intangible Assets	338.99	359.22	450.39	443.85	631.99	432.98
Long-Term Accounts Receivable	-	-	-	0	0	-0
Other Long-Term Assets	6.74	6.74	28.11	31.88	85.2	198.27
Total Assets	43,686	46,535	43,715	52,917	55,689	67,879

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	998.41	868.51	428.33	357.38	249.06	226.04
Short-Term Debt	7,771	7,098	7,280	1,803	10,454	-
Current Portion of Leases	12.44	12.43	21.14	262.66	415.2	198.59
Other Current Liabilities	4,077	4,265	8,571	16,975	11,136	1,464
Total Current Liabilities	12,859	12,244	16,301	19,398	22,254	1,888
Long-Term Debt	-	-	-	-	-	8,152
Long-Term Leases	12.85	15.58	12.39	27.94	251.65	485.11
Pension & Post-Retirement Benefits	2,407	2,429	2,240	2,071	1,570	1,337
Other Long-Term Liabilities	72.3	67.5	218.59	191.29	152.09	28,389
Total Liabilities	15,351	14,756	18,772	21,688	24,228	40,252

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	12,129	12,129	7,629	7,615	6,759	6,750
Additional Paid-In Capital	111,848	111,848	92,583	92,602	80,933	73,428
Retained Earnings	-97,325	-93,833	-76,293	-69,018	-57,452	-53,051
Comprehensive Income & Other	1,683	1,634	1,024	29.3	1,221	500.14
Shareholders' Equity	28,336	31,779	24,943	31,228	31,461	27,627
Total Liabilities & Equity	43,686	46,535	43,715	52,917	55,689	67,879

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	7,797	7,126	7,314	2,094	11,121	8,836
Net Cash (Debt)	5,601	9,219	4,752	17,574	24,222	43,873
Net Cash Growth	-	94.01%	-72.96%	-27.45%	-44.79%	9.50%
Net Cash Per Share	314.12	591.78	311.60	1227.54	1792.34	3258.50
Filing Date Shares Outstanding	24.26	24.26	15.26	15.23	13.52	13.5
Total Common Shares Outstanding	24.26	24.26	15.26	15.23	13.52	13.5
Working Capital	2,029	5,186	-3,736	2,581	15,242	56,305
Book Value Per Share	1168.07	1310.02	1634.71	2050.38	2327.37	2046.46
Tangible Book Value	27,997	31,420	24,493	30,784	30,829	27,194
Tangible Book Value Per Share	1154.09	1295.21	1605.20	2021.24	2280.62	2014.38
Land	4,954	4,954	4,954	4,954	4,936	4,936
Buildings	22,355	22,355	22,355	22,335	-	-
Machinery	9,783	9,771	9,912	7,562	6,144	5,654
Construction In Progress	171.33	-	-	-	9,212	208

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error